Literature DB >> 25433553

Lactobacillus rhamnosus GG Reverses Insulin Resistance but Does Not Block Its Onset in Diet-Induced Obese Mice.

Kun-Young Park1, Bobae Kim1, Chang-Kee Hyun1.   

Abstract

Recently, Lactobacillus rhamnosus GG (LGG) was shown to exert insulin-sensitizing and adiposity-reducing effects in high-fat (HF) diet-fed mice. In the present study, we observed that the effects were correlated with the extent of dysbiosis induced by HF diet feeding before LGG administration. LGG-treated mice were protected from HF diet-induced adiposity and/ or insulin resistance when LGG was treated after, not along with, HF diet feeding. Results indicate that, under HF dietary condition, supplemented LGG reverses insulin resistance, but does not block its onset.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25433553     DOI: 10.4014/jmb.1409.09016

Source DB:  PubMed          Journal:  J Microbiol Biotechnol        ISSN: 1017-7825            Impact factor:   2.351


  3 in total

Review 1.  Gut microbiota and obesity.

Authors:  Philippe Gérard
Journal:  Cell Mol Life Sci       Date:  2015-10-12       Impact factor: 9.261

2.  Isolated exopolysaccharides from Lactobacillus rhamnosus GG alleviated adipogenesis mediated by TLR2 in mice.

Authors:  Zhen Zhang; Zhigang Zhou; Yu Li; Linkang Zhou; Qianwen Ding; Li Xu
Journal:  Sci Rep       Date:  2016-10-27       Impact factor: 4.379

3.  A randomized clinical trial examining the impact of LGG probiotic supplementation on psychological status in middle-aged and older adults.

Authors:  Victoria Sanborn; M Andrea Azcarate-Peril; John Updegraff; Lisa M Manderino; John Gunstad
Journal:  Contemp Clin Trials Commun       Date:  2018-11-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.